QualityStocksNewsBreaks Archives - Page 228 of 1272

ThursdaySep 15, 2022 3:03 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILOD) Implements Reverse Stock Split in Preparation for Nasdaq Uplisting

Silo Pharma (OTCQB: SILOD), a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it will effect a 1-for-50 reverse split of its common stock. Effective at the open of business on Thursday, Sept. 15, 2022, the reverse stock split is in preparation for the planned listing of the company’s securities on the Nasdaq Capital Market (“Nasdaq”). The company’s common stock has begun trading on the OTC Markets system on a split-adjusted basis under the temporary ticker symbol SILOD. The fifth character “D” will remain appended to Silo Pharma’s symbol for 20 business days or…

ThursdaySep 15, 2022 2:54 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Secures Expanded Contract with Oregon-Based Client

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that a locally owned, Oregon-based healthcare system has expanded its contract for its many facilities in the state. The announcement reads, “On the heels of securing a contract for a Knightscope K5 Autonomous Security Robot (‘ASR’), the new client has increased its order for an additional 2 K5 ASRs. The client has a children’s hospital, a 24-hour mental and behavioral health services center, and more than 70 primary care, specialty and urgent care clinics. The hospital’s goal is to deter criminal activity,…

ThursdaySep 15, 2022 1:34 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Hypertension Treatment Program Stands Distinct

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently provided information to its stakeholders to help them conveniently research and understand different non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. The information includes a discussion of underlying logic-based evaluations that offer a realistic framework of expectations that investors can use in their analysis. “One of the logic-based evaluations considers the stage at which a company’s drug development program has reached. According to the U.S. Food and Drug Administration (‘FDA’), there are five steps to the drug development process: discovery and development, preclinical research, clinical research, FDA drug review, and,…

ThursdaySep 15, 2022 1:22 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd.’s (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Solutions Hold Potential to Disrupt Electrification Industry

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA), a clean technology company, addresses the design and mechanical challenges faced by manufacturers in the EV space, which are brought by inverter size and power density. The company’s conversion technologies and control systems solutions reduce the size and weight of inverter designs with the potential to disrupt the electrification industry. “Enabling switching at higher frequencies with Hillcrest’s Zero Voltage Switching (‘ZVS’) inverter technology can result in a significant increase in power density, partly due to the reduction in the size of capacitors needed and in turn reducing the overall size, weight and cost…

ThursdaySep 15, 2022 12:29 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Provides First Look at Its Ultra-High-Performance FIVE RS

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced specifications and unveiled details on the FIVE RS - its ultra-high-performance EV sport crossover. The Mullen FIVE RS will be equipped with 800-volt architecture, all-wheel drive, a two-speed gearbox and over 1,000 horsepower and feature a top speed of 200 mph and acceleration from 0-60 mph in just 1.9 seconds. “From the inception of Mullen, it has been my mission to bring an ultra-high-performance EV to market,” said David Michery, CEO and chairman of Mullen Automotive. “The FIVE RS is intended to be one of the fastest vehicles…

ThursdaySep 15, 2022 11:52 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures Additional IP Protection for Breakthrough ECG Patch Technology

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, today announced issuance of its patent for a 12-lead electrocardiogram (“ECG”) patch monitor intended for detection of acute coronary syndrome (“ACS”) and cardiac arrhythmia by the United States Patent and Trademark Office. According to the update, the innovation builds on HeartBeam’s growing intellectual property portfolio enabling 12-lead ECG diagnostics outside of a medical setting. “This patent provides additional intellectual property protection for our breakthrough ECG patch technology, offering 12-lead ECG capability in the form of a simple…

ThursdaySep 15, 2022 11:40 am

QualityStocksNewsBreaks – Home Bistro Inc. (HBIS) Announces Q3 2022 Financial Results

Home Bistro (OTC: HBIS), a leading online meal delivery platform that offers celebrity chef-inspired, gourmet and lifestyle ready-made meals, today released financial results for its third quarter ended July 31, 2022. “In addition to our ongoing menu expansion of celebrity chef meals over the past several quarters, we have also undertaken the following initiatives, which we expect to have a net positive effect on gross margin growth moving forward: reduced royalty payments to newly added celebrity chefs; reduced product costs; established new multi-tier pricing; commenced charging a fee for shipping; reduced product promotions,” said Home Bistro CEO Zalmi Duchman. “We’ve…

ThursdaySep 15, 2022 11:33 am

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Participation in H.C. Wainwright Global Investment Conference

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process as well as providing a platform for business-to-business (“B2B”) cross-border shipping in the United States/Mexico/Canada (“USMC”) region, will be presenting today at the H.C. Wainwright 24th Annual Global Investment Conference. Scheduled for Sept. 12–14, the three-day conference has been held in New York City as a hybrid event; participants have been attending both in person and online. Freight Technologies president Mike Flinker and CFO Paul Freudenthaler presented today, and their presentation will be available throughout the day for participants to view. To view…

ThursdaySep 15, 2022 11:23 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Uplists to OTCQX Market Exchange

EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, announced an important milestone for the company: its common shares began trading on the OTCQX(R) Best Market in the United States. The shares are trading under the symbol EVGIF, and the uplisting was effective at market open on Sept. 15, 2022. The company had previously traded under the same symbol on the OTCQB(R) Venture Market. According to the announcement, the OTCQX market is an established market that provides qualifying companies with an opportunity to increase visibility, expand liquidity and diversify shareholder base. The exchange is recognized by…

WednesdaySep 14, 2022 12:34 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Marking Industry’s First-Ever Entry of Novel Psilocybin Analog into Clinical Development

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is making significant headway with its flagship deuterated psilocybin analog, CYB003. “CYB003 has the potential to effectively treat alcohol use disorder (‘AUD’) and major depressive disorder (‘MDD’). The substance is designed to achieve less variability in plasma levels, faster onset of action, shorter duration of effect, and potentially better tolerability than oral psilocybin for a better patient outcome overall. Earlier this summer, Cybin received a ‘may proceed’ letter and Investigational New Drug Application (‘IND’) clearance from the U.S.…

Site Search

Company Search

Category: QualityStocksNewsBreaks